LT Clinical Research (Pty) Ltd, trading as LT Clinical Research, is an independent contract healthcare research organization providing clinical trials management services in Africa, including GxP consulting for pharmaceutical, biotechnology, and medical devices companies.
The CRO is headquartered in Pretoria, South Africa. We aim to be a CRO of choice for clinical trials in Africa. We employ qualified and experienced professionals in all our operations. At LT Clinical Research, we are committed to better understand the needs of our clients and providing professional, flexible and personalized service that will result in our client’s ability to achieve the project goals in time and at significant cost savings.
LT Clinical Research provides a full range of expert services in the following areas:
1. Clinical Trial Management Services – conduct Phase I – IV contract clinical trials in Africa on behalf of international and local sponsors.
2. GxP Consulting Services– Assist and support pharmaceutical companies in Africa to achieve GMP compliant quality management systems within defined timelines and cost effectively.
3. Regulatory Submission and Support – provide expertise to assist clients navigate through regulatory affairs.
Contact Details
+27 (0) 82 374 9985
+27 (0) 83 978 7077
The founder and managing director of LT Clinical Research, one of the first wholly black-owned South African CRO, reveals how South Africa is a very conducive environment for CROs, with…
Medicines for Africa’s Lenias Hwenda argues that the success of the much-talked-about African Medicines Agency hinges on a critical mass of African national regulators achieving WHO Level 3 maturity status.…
Writing in the February 2024 edition of the DIA Global Forum magazine, Verena Pfaffinger and Ilona Baraniak-Lang of PharmaLex examine how the drug shortages seen in the global south during…
Tremendous strides have been made in both treatment and prevention of AIDS and it is no longer among the 10 leading causes of death globally, however an estimated 39 million…
Dr Benji Pretorius, the founder of Erada Technology Alliance and a malaria survivor himself, shares his insights into why the development of a truly effective malaria vaccine will only succeed…
Writing in the July 2023 edition of DIA’s Global Forum magazine, Nevena Miletic of Roche and the IFPMA’s Africa Regulatory Network and Ian Hudson from the Bill and Melinda Gates…
The third and final piece in Lenias Hwenda of Medicines for Africa’s series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential…
The second in a three-part series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential medical breakthroughs to come (read part one…
In the first of a series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential medical breakthroughs to come, Lenias Hwenda of…
During the COVID-19 pandemic discussions around increasing access to medicines for low and middle-income countries (LMICs) were often centred on compulsory licensing. As a result, pharma companies were up in…
As part of a special focus on drug development and clinical research in Africa in February 2023’s DIA Global Forum magazine, Lisa Ursella Collins of Innomas Clinical Research, Leslie Sam…
Roughly half of Africa’s 1.1 billion people lack regular access to even the most essential medicines and most of Sub-Saharan Africa depends on imports which make up as much as…
Speaking exclusively to PharmaBoardroom, Medicines for Africa’s Lenias Hwenda gives a comprehensive overview of the African Medicines Agency, why such a regulatory body was needed, how it differs from the…
See our Cookie Privacy Policy Here
